tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MRNA Stock Latest News

Prasad appointment not necessarily bad news for biopharma, says Citi
The FlyPrasad appointment not necessarily bad news for biopharma, says Citi
9h ago
BNTX
MRNA
SPY ETF News, 5/7/2025
PremiumMarket News
SPY ETF News, 5/7/2025
9h ago
F
MU
Controversial doctor Vinay Prasad named CBER director, STAT reports
PremiumThe Fly
Controversial doctor Vinay Prasad named CBER director, STAT reports
1d ago
DYN
RNA
Cautious Outlook for Moderna Amid Cost Containment and Revenue Uncertainties
PremiumRatings
Cautious Outlook for Moderna Amid Cost Containment and Revenue Uncertainties
2d ago
MRNA
Moderna’s Financial Outlook: Sell Rating Amid Challenging Vaccine Environment and Cost Reductions
PremiumRatings
Moderna’s Financial Outlook: Sell Rating Amid Challenging Vaccine Environment and Cost Reductions
2d ago
MRNA
Moderna price target lowered to $70 from $78 at UBS
PremiumThe FlyModerna price target lowered to $70 from $78 at UBS
5d ago
MRNA
Moderna price target lowered to $28 from $32 at RBC Capital
Premium
The Fly
Moderna price target lowered to $28 from $32 at RBC Capital
5d ago
MRNA
VOO ETF News, 5/2/2025
Premium
Market News
VOO ETF News, 5/2/2025
5d ago
F
ED
Moderna price target lowered to $40 from $45 at Barclays
PremiumThe Fly
Moderna price target lowered to $40 from $45 at Barclays
5d ago
MRNA
Moderna’s Q1 2025: Revenue Decline and Strategic Focus
PremiumCompany Announcements
Moderna’s Q1 2025: Revenue Decline and Strategic Focus
6d ago
MRNA
Moderna’s Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Moderna’s Earnings Call: Progress Amid Challenges
6d ago
MRNA
Moderna price target lowered to $28 from $32 at RBC Capital
PremiumThe Fly
Moderna price target lowered to $28 from $32 at RBC Capital
6d ago
MRNA
Moderna’s Strategic Shift Amidst Financial Challenges and Market Uncertainties: Analyst Maintains Hold Rating with Adjusted Target Price
PremiumRatingsModerna’s Strategic Shift Amidst Financial Challenges and Market Uncertainties: Analyst Maintains Hold Rating with Adjusted Target Price
6d ago
MRNA
Moderna price target lowered to $32 from $40 at Citi
Premium
The Fly
Moderna price target lowered to $32 from $40 at Citi
6d ago
MRNA
Moderna’s Strategic Outlook: Balancing Cautious Optimism with Competitive Challenges
Premium
Ratings
Moderna’s Strategic Outlook: Balancing Cautious Optimism with Competitive Challenges
6d ago
MRNA
Moderna’s Stable Outlook Amid Regulatory Challenges and Revenue Projections Justifies Hold Rating
PremiumRatings
Moderna’s Stable Outlook Amid Regulatory Challenges and Revenue Projections Justifies Hold Rating
6d ago
MRNA
Moderna sees extended review timeline for flu plus COVID vaccine
PremiumThe Fly
Moderna sees extended review timeline for flu plus COVID vaccine
6d ago
MRNA
Trump Trade: RFK Jr. invests $500M in universal vaccine project
PremiumThe Fly
Trump Trade: RFK Jr. invests $500M in universal vaccine project
6d ago
GM
PFE
MRNA Earnings: Moderna Stock Catches a Cold as More ‘Normal’ Covid Hits Revenues
PremiumMarket News
MRNA Earnings: Moderna Stock Catches a Cold as More ‘Normal’ Covid Hits Revenues
6d ago
MRNA
MRNA Earnings: Shares Slump as Moderna Reveals Covid Hit to Revenues
PremiumMarket NewsMRNA Earnings: Shares Slump as Moderna Reveals Covid Hit to Revenues
6d ago
MRNA
Mixed Financial Performance and Pipeline Progress Lead to Hold Rating on Moderna
Premium
Ratings
Mixed Financial Performance and Pipeline Progress Lead to Hold Rating on Moderna
6d ago
MRNA
Moderna reports Q1 EPS ($2.52), consensus ($3.18)
Premium
The Fly
Moderna reports Q1 EPS ($2.52), consensus ($3.18)
6d ago
MRNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >